Timothy P Kelly Homology Medicines, Inc. (FIXX) insider trading activity
Timothy P Kelly is Chief Operating Officer of Homology Medicines, Inc.. Currently has a direct ownership of 2,224 shares of FIXX, which is worth approximately $0. The most recent transaction as insider was on Jan 05, 2022, when has been sold 1,406 shares (Common Stock) at a price of $3.78 per share, resulting in proceeds of $5,315. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
2.22K
0%
3M change
0%
12M change
Total Value Held
$0
Timothy P Kelly Transaction History
Also insider at
TPK
Timothy P Kelly
Chief Operating Officer
Bedford, MA